Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations)

Hyperparathyroidism in Patients with End-Stage Chronic Liver Disease (Clinical Observations)

Aim: to present disorders of mineral and bone metabolism in patients with chronic liver diseases through clinical observations.Key points. The liver plays an important role in mineral metabolism: metabolic activation of vitamin D, synthesis of vitamin D-binding protein and albumin, metabolism of par...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. A. Lavreniuk, A. N. Gorbacheva, E. E. Bibik, A. K. Eremkina, I. N. Tikhonov, N. G. Mokrysheva
Format:	Article
Language:	Russian
Published:	Gastro LLC 2024-12-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	hyperparathyroidism chronic liver diseases liver cirrhosis osteoporosis
Online Access:	https://www.gastro-j.ru/jour/article/view/984
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anesthesia in Parathyroidectomy for Secondary Hyperparathyroidism of Chronic Kidney Disease
by: ZHANG Yangyang, et al.
Published: (2024-11-01)

Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center
by: Ye. N. Bessonova, et al.
Published: (2013-12-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

Generalized tuberculosis with long-term course in the guise of liver cirrhosis
by: Z. A. Lemeshko, et al.
Published: (2015-07-01)

Alcohol-induced liver disease: primary and secondary prevention
by: S. V. Plyusnin, et al.
Published: (2015-07-01)

Nutritional assessment using subjective global assessment identifies energy malnutrition and predicts mortality in patients with liver cirrhosis
by: Takao Miwa, et al.
Published: (2025-02-01)

Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C
by: A. A. Konysheva, et al.
Published: (2012-11-01)

Structure of Patients with Hepatocellular Cancer (Data Analysis from Two Specialised Centres)
by: M. V. Mayevskaya, et al.
Published: (2020-05-01)

Leading causes of fever in patients with liver function disorders
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Pathology of the Gastrointestinal Tract in Patients with Primary Hyperparathyroidism
by: I. A. Baranova, et al.
Published: (2023-02-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Managing Liver Cirrhosis: a Multidisciplinary Approach
by: V. M. Durleshter, et al.
Published: (2020-09-01)

Clinical Practice Guidelines of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the National Scientific Society of Infectious Disease Specialists for the Diagnosis and Treatment of Chronic Hepatitis C
by: V. T. Ivashkin, et al.
Published: (2023-06-01)

Complex application of mathematical methods in diagnostics of diffuse liver diseases
by: I. Yu. Pirogova, et al.
Published: (2011-02-01)

Efficacy of silymarinum at chronic diffuse liver diseases
by: A. V. Matvieiev, et al.
Published: (2011-09-01)

Gene therapy by hepatocyte growth factor results in regression of experimental liver fibrosis
by: N. A. Dzhoyashvili, et al.
Published: (2010-08-01)

Investigation of hemostasis by thromboelastography in the patient with liver cirrhosis (Clinical case)
by: Ye. L. Bulanova, et al.
Published: (2011-12-01)

Thromboelastography parameters in chronic viral liver disease and liver resection: a retrospective study
by: Ying Di, et al.
Published: (2024-08-01)

Screening investigation of patients with diffuse liver diseases
by: I. Yu. Pirogova
Published: (2010-06-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Hypercoagulation syndrome at liver cirrhosis
by: I. A. Kurkina, et al.
Published: (2014-12-01)

Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis
by: K. S. Zemlyanukhina, et al.
Published: (2024-10-01)

Impact of acute respiratory distress syndrome on outcome in critically ill patients with liver cirrhosis
by: Pischtaz Adel Tariparast, et al.
Published: (2025-02-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Mediators of intercellular interactions and histological signs of chronic viral liver disease
by: P. V. Koroy, et al.
Published: (2014-11-01)

Triple antiviral therapy in patient with liver cirrhosis: complications and options of pharmacological treatment
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

Parameters of the Component Composition of the Body and Their Relationship with the Development of Ascites in Liver Cirrhosis
by: Yu. O. Zharikov, et al.
Published: (2024-08-01)

Lifetime of patients and prognostic value of manifestations and complications of liver cirrhosis
by: G. K. Mirodzhov, et al.
Published: (2010-11-01)

Supplemental technologies of liver ultrasound investigation at the 1-st type tyrosinemia in pediatrics
by: G. M. Dvoryakovskaya, et al.
Published: (2015-12-01)

Large intestinal pathology at liver cirrhoses
by: M. V. Safonova, et al.
Published: (2012-07-01)

Laboratory diagnostics of alcohol intoxication in patients with alcohol-induced liver disease
by: A. I. Pavlov, et al.
Published: (2010-02-01)

Treatment of biliary cysts of the liver and polycystic liver disease: a surgical view
by: M. P. Kochieva, et al.
Published: (2010-02-01)

Potential of albumin dialysis at terminal liver failure in patients with chronic liver diseases
by: O. E. Nikiforova, et al.
Published: (2010-08-01)

Cholestasis in Chronic Liver Disease and the Role of Ademetionine in its Treatment (Literature Review and Expert Panel Resolution)
by: K. L. Raikhelson, et al.
Published: (2024-10-01)

Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)

Structure and Functions of Human Serum Albumin in Normal Conditions and in Patients with Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2022-12-01)

Successful living donor liver transplantation of the left lateral sector with simultaneous atypical resection of the S2 for focal nodular hyperplasia
by: R. T. Rzayev, et al.
Published: (2022-05-01)

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study
by: Hui Liu, et al.
Published: (2025-01-01)